https://www.selleckchem.com/pr....oducts/Epinephrine-b
Lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are two major subtypes of non-small cell lung cancer (NSCLC). Studies have shown that abnormal expression of glucose transport type 1 (GLUT1) in NSCLC patients has been associated with progression, aggressiveness, and poor clinical outcome. However, the clinical effect of GLUT1 expression on LUAD and LUSC is unclear. This study aims to learn more about the character of GLUT1 in LUAD and LUSC. A meta-analysis was performed to evaluate the GLUT1 prot
Like
Comment
Share
